Latest News and Press Releases
Want to stay updated on the latest news?
-
Appointments strengthen Diginex’s operational and governance capabilities as Company executes unified platform strategyJacob Friedman to lead integration of customer operations across all four...
-
GAITHERSBURG, Md., April 02, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS), a global life sciences leader with biodefense and medical countermeasures products, announced today that...
-
2 APRIL 2026 NORTHERN 2 VCT PLC ISSUE OF EQUITY AND TOTAL VOTING RIGHTS Northern 2 VCT PLC (“the Company”) announces that on 2 April 2026 it allotted 17,238,349 ordinary shares of 5p each in...
-
2 APRIL 2026 NORTHERN 3 VCT PLC ISSUE OF EQUITY AND TOTAL VOTING RIGHTS Northern 3 VCT PLC (“the Company”) announces that on 2 April 2026 it allotted 20,180,102 ordinary shares of 5p each in...
-
RESTON, Va., April 02, 2026 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge” or the “Company”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, today announced that President...
-
MIAMI BEACH, Fla., April 02, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today...
-
ProVen VCT plc Issue of Equity2 April 2026 The Directors of ProVen VCT plc announce an allotment on 2 April 2026 of ordinary shares of 10p each ("Ordinary Shares") pursuant to the offer for...
-
ProVen Growth and Income VCT plcIssue of Equity2 April 2026 The Directors of ProVen Growth and Income VCT plc announce an allotment on 2 April 2026 of ordinary shares of 1.6187p each ("Ordinary...
-
Lichen planopilaris (LPP) is a highly morbid inflammatory scalp disorder that causes generally irreversible scarring hair loss, often accompanied by profound pain, itch, and burning sensations; no...
-
Volta Finance Limited (VTA/VTAS) Publication of the Half-Yearly Financial Reportfor the period from 1 August 2025 to 31 January 2026 NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN...